
















Description
Job DescriptionGeneral Summary:
The Marketing Operations Senior Specialist - (Editor) supports/facilitates the Communications Review Committee (CRC) review and approval, production, and distribution of branded and non-branded communications for assigned region and other headquarters-based functions. This position guides Marketing and other key functions through the CRC submission and review of promotional, educational, and training materials. This role provides editorial guidance during internal review of commercial content. This role is the liaison between the Marketing/Brand teams, agency partners, and the CRC (Medical, Legal, Regulatory) team.
Key Duties and Responsibilities:
Knowledge and Skills:
Education and Experience:
#LI-Hybrid
#LI-SR1
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition atApplicationAssistance@vrtx.com.
Job Information
- Job ID: 69507756
- Workplace Type: On-Site
- Location:
Boston, Massachusetts, United States - Company Name For Job: Vertex Pharmaceuticals
- Position Title: Marketing Operations Senior Specialist - Editor
- Job Function: Other / Not Listed
- Job Type: Full-Time
At Vertex, we bring together the brightest minds in the relentless pursuit of creating transformative medicines for people with serious and life-threatening diseases. Founded in 1989 in Cambridge, Massachusetts, we are one of only a handful of biotechnology companies founded since 1976 that has discovered and developed four or more approved medicines in our own labs. In addition to the four medicines we’ve developed to treat the underlying cause of cystic fibrosis, we have ongoing research programs focused on the underlying ...


